Meta description: This regulatory update summarizes a voice controlled exoskeleton trial for stroke upper limb rehabilitation and notes its not yet recruiting status and sponsor details.
As of 2026 02 19, a Taipei based clinical study is testing whether inviting patient intention through voice can enhance rehabilitation when using a single joint robot for upper limb therapy in stroke patients.
What changed in this regulatory update
The study titled Voice Induced Motor Intention to Enhance Upper Limb Rehabilitation Efficacy of Exoskeleton Robots for Stroke Patients is listed on ClinicalTrials.gov with identifier NCT07398131. As of 2026 02 19 the status is Not yet recruiting. The study is conducted in Taipei and is supported by Taipei Hospital and the Ministry of Health and Welfare. The ClinicalTrials.gov entry provides the public link to the record.
Public record is accessible at ClinicalTrials.gov entry NCT07398131.
What is the trial design and what interventions are used
The trial uses a two arm design to compare two device modes in a single joint robot used for upper limb therapy after stroke. The active mode is described as voice controlled by the user, intended to promote motor engagement. The second arm uses a passive mode where movement is not driven by user voice input. The interventions are Device: single joint robot with active voice controlled mode and Device: single joint robot in passive mode.
The objective is to understand whether increasing the willingness to exercise can improve upper limb motor activation during rehabilitation with the exoskeleton robot.
Who sponsors and what is recruitment status
Sponsors listed for the study are Taipei Hospital and the Ministry of Health and Welfare. The record indicates the trial is not yet recruiting as of the release date in February 2026. The sponsor information is publicly posted on ClinicalTrials.gov.
What is the trial context and regulatory implications
The research uses a rehabilitation device in a clinical setting for stroke patients and reflects an increasing focus on patient engaged therapies for upper limb recovery. The use of voice input aims to align patient intention with device driven movement, a concept that intersects with device safety and patient safety oversight. The trial is registered on ClinicalTrials.gov under NCT07398131 and the external link is provided for transparency.
What this means for regulatory affairs and patient care
For regulators and device developers, the update highlights how patient engagement features can be incorporated in rehabilitation exoskeleton devices while ensuring safety and informed consent. The two mode arms illustrate a straightforward but meaningful approach to trialing user driven motor assistance. Stakeholders should monitor recruitment progress and ensure terminology remains clear and non conflicting with regulatory requirements.
FAQ
- Q1. What device is being tested? A1. A single joint robot with active voice controlled mode and a passive mode are used in two arms.
- Q2. How many arms are compared? A2. Two arms are compared in a two arm design: active voice controlled and passive.
- Q3. Who sponsors the study? A3. Taipei Hospital and the Ministry of Health and Welfare are sponsors.
- Q4. What is the recruitment status? A4. The trial is not yet recruiting as of 2026 02 19.
Conclusion
In summary, a regulatory update covers a voice driven exoskeleton trial for stroke upper limb rehabilitation. The study may influence future device design and patient care in rehabilitation settings. Stakeholders should track recruitment and await outcomes.
Disclaimer
This information is intended for professionals and is not legal advice. It does not replace regulatory guidance or official communications from authorities.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07398131?term=medical+device